[18F]NOTA-ABY-030

N/A

Report date: 2026/05/12 20:00:17

Base Information

Drug Name[18F]NOTA-ABY-030
Drug Alias Name18F-NOTA-ABY-030
ClassificationBiologicsRadiation-emitting products > Nuclides > Fluorine > 18F
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSquamous Cell Carcinoma of Head and NeckCarcinoma, Squamous Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVanderbilt-Ingram Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesVanderbilt-Ingram Cancer Center
Inactive CompaniesN/A
Active IndicationsSquamous Cell Carcinoma of Head and NeckCarcinoma, Squamous Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A